Results 61 to 67 of about 67 (67)

[Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Chinese Society of Hepatology, Chinese Medical Association.   +1 more
europepmc   +1 more source

[Expert panel consensus statement on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2016)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi, 2016
Chinese Society of Clinical Oncology (CSCO), Chinese Society of Hematology (CSH), Union for China Lymphoma Investigators (UCLI).   +2 more
europepmc   +1 more source

[Consensus on the diagnosis and therapy of hepatic fibrosis in]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2019
Chinese Society of Hepatology Chinese Medical Association, Chinese Society of Gastroenterology Chinese Medical Association, Chinese Society of Infectious Diseases, Chinese Medical Association.   +3 more
europepmc   +1 more source

[Diagnosis, management, and treatment of hepatocellular carcinoma (V2017)]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2017
Bureau of Medical Administration, National Health and Family Planning Comission of the People's Republic of China.   +1 more
europepmc   +1 more source

[Diagnosis and treatment guideline on drug-induced liver injury]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2015
Study of Drug Induced Liver Disease of Chinese Medical Association.
europepmc   +1 more source